Fed Circuit Watch: Claim Construction Before Patent-Eligibility Analysis

101 fed circuit watch patent patent eligible subject matter

There have been several patent-eligibility rulings by the Court of Appeals for the Federal Circuit this year, but on August 16, 2019, the Fed Circuit held that claim construction in-dispute must be resolved before patent-eligibility under 35 U.S.C. §101 can be analyzed, in MyMail, Ltd. v. ooVoo, LLC.[1]  The somewhat circuitous procedural aspects of this …

Continue Reading

CannabIP: U.S. Patent No. 10,258,601 B1

Cannabis IP patent

U.S. Patent No. 10,258,601 B1 (‘601) issued on April 16, 2019, for “Vaporizable Cannabinoid Compositions.”  It was issued to applicant/inventor Stephen C. Perry, of Norwood, Massachusetts.  The specification discloses the composition of the vaporizable cannabis solution disclosed as comprising various Markush groups, including different formulations of the Cannabis plant, cannabinoids, bioactive ingredients, cannabinomimetics, and fatty …

Continue Reading

Fed Circuit Watch: Valuable Contribution Is Not Necessarily Patent-Eligible

101 fed circuit watch patent patent eligible subject matter

In a strange ruling by the Court of Appeals for the Federal Circuit, on July 29, 2019, although publicly released on August 9, 2019, in Genetic Veterinary Scis., Inc. v. Laboklin GmbH & Co KG,[1] the Fed Circuit found that in spite of the claimed invention’s “valuable contribution” to the veterinary sciences, it remained outside …

Continue Reading

CannabIP: U.S. Patent No. PP30,668 P3

Cannabis IP patent plantIP

U.S. Patent No. PP30,668 P3 (‘668) issued on July 9, 2019, for “Cannabis Plant Named ‘DD-CT-BR5’.”  It was issued to inventor David Holmes of San Gabriel, California.  The applicant/assignee is Cannagen, LLC, of San Gabriel, California.  This patent is a plant patent under 35 U.S.C. §161, which protects new and distinct cultivars of plants.  According …

Continue Reading

Fed Circuit Watch: IPRs Not Unconstitutional Taking Under Fifth Amendment

5th amendment fed circuit watch IPR patent

Many cases have been heard before the Court of Appeals for the Federal Circuit dealing with substantive patent issues, like questions involving anticipation under 35 U.S.C. §102, obviousness under 35 U.S.C §103, or patent-eligible subject matter under 35 U.S.C. §101.  Constitutional issues have been rare, with the exception of Oil States which questioned the constitutionality …

Continue Reading

TechPat: Former Uber Self-Driving Leader Indicted for Trade Secrets Theft

patent Tech Patents technology trade secrets

The United States Attorney’s office in San Jose, California, recently indicted Uber Technologies, Inc.’s former autonomous driving car guru, Anthony Levandowski, with thirty-three counts of trade secrets theft in violation of 18 U.S.C. §§1832(a)-(d).  The indictment was only released on August 27, 2019, after being unsealed by the federal district court judge presiding over the …

Continue Reading

TechPat: U.S. Patent No. 10,360,269 B2

patent Tech Patents technology

The Oracle OpenWorld 2019 conference will be held in San Francisco from September 16-19, 2019.  To commemorate Oracle OpenWorld, the blog will highlight a recently-issued Oracle, Inc. patent. U.S. Patent No. 10,360,269 B2 (‘269), issued on July 23, 2019, for “Proxy databases.”  The inventor is Thomas Baby of Auburn, Washington.  The applicant and assignee is …

Continue Reading

TechPat: Gilead Petitions for IPR on Truvada Patents

patent Tech Patents

On August 23, 2019, Gilead Sciences, Inc. petitioned the PTAB for inter partes review of three patents behind its blockbuster TRUVADA® HIV-prevention drug.  The patents, U.S. Patent No. 9,044,509 (‘509), 9,579,333 (‘333), and 9,937,191 (‘191) were all filed by the U.S. Department of Health and Human Services, and the federal agency is still listed as …

Continue Reading